MEDtalks: kort faglig opdatering

Hør kollegaer / specialister berette kort om specifikke emner med relevans for patientbehandling indenfor Almen praksis, Onkologer, Hæmatologer, osv.

Almen praksis

3:19

Hurtigere diagnostik af myelomatose

Med ganske få virkemidler er det muligt at afgøre, om dine patien…

<script src="https://fast.wistia.com/embed/medias/vlld4boamp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vlld4boamp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:28

Myelomatose – materialer der kan hjælpe patient og pårørende

Myelomatose Foreningen har diverse støttematerialer, der kan være…

<script src="https://fast.wistia.com/embed/medias/j7lf7atgdj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j7lf7atgdj videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:45

Myelomatose – en reminder til at hjælpe i udredningen

Her får du viden om en god reminder lavet af Myelomatose Foreninge…

<script src="https://fast.wistia.com/embed/medias/2upk7gfomy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2upk7gfomy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:40

Myelomatose - en sygdom der let overses

Myelomatose, en ikke-kurabel hæmatologisk sygdom, hvis symptomer e…

<script src="https://fast.wistia.com/embed/medias/xq3bn7xp0s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xq3bn7xp0s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
20:50

Forekomst og behandling af kardiovaskulær sygdom hos diabetespatienter i almen praksis

En ny dansk undersøgelse viser, at et stort antal diabetespatiente…

<script src="https://fast.wistia.com/embed/medias/0xvytwmqjy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xvytwmqjy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:55

Kontrol i almen praksis efter ablation

Når patienter med atrieflimren har fået foretaget ablation, udskr…

<script src="https://fast.wistia.com/embed/medias/lexvg7knyo.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lexvg7knyo videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:07

Diabetisk nefropati - Farmakologisk behandling

Søren Tang Knudsen, overlæge på Medicinsk Endokrinologisk afdeli…

<script src="https://fast.wistia.com/embed/medias/g1oss1f9hm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_g1oss1f9hm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:43

Diabetisk nyresygdom og mikroalbuminuri - Forebyggelse og behandling

I dette andet modul af MEDtalk’en om Diabetisk nyresygdom og mikr…

<script src="https://fast.wistia.com/embed/medias/f1svl50kls.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f1svl50kls videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:34

Diabetisk nyresygdom og mikroalbuminuri - Screening og naturhistorie

Med fokus på screening og naturhistorie vil Søren Tang Knudsen, o…

<script src="https://fast.wistia.com/embed/medias/0z1hbge3d8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0z1hbge3d8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:36

Hvad skal få mig, som læge, til at tænke ADHD?

I denne MEDtalk beskriver speciallæge i børne-/ungepsykiatri Jaco…

<script src="https://fast.wistia.com/embed/medias/yji6kccwys.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yji6kccwys videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:43

Spørgsmål fra almen praksis om type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/j69ca6c5pz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j69ca6c5pz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
12:34

Valg af behandling når patienten har type 2-diabetes og hjertesygdom

<script src="https://fast.wistia.com/embed/medias/m97eojk57i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_m97eojk57i videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:14

Klassiske senkomplikationer ved type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/64ekomhzrm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_64ekomhzrm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
27:55

Ablationsbehandling af atrieflimren – Hvem, hvornår og hvordan?

<script src="https://fast.wistia.com/embed/medias/2na6xy142g.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2na6xy142g videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:16

Spørgsmål til hvordan man reducerer forbruget af steroid hos KOL patienter

Pensioneret praktiserende læge, nu lægevikar Mogens Jacobsen svar…

<script src="https://fast.wistia.com/embed/medias/3p9obtegfn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3p9obtegfn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:45

Behandlingen af KOL patienter

Pensioneret praktiserende læge, nu lægevikar, Mogens Jacobsen gen…

<script src="https://fast.wistia.com/embed/medias/6jyygwwhzz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6jyygwwhzz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:44

Gode grunde til at seponere inhalationssteroid

Pensioneret praktiserende læge, nu lægevikar, Mogens Jacobsen gen…

<script src="https://fast.wistia.com/embed/medias/px72uhb0tr.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_px72uhb0tr videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:31

Algoritme for behandling ved type 2-diabetes

I dette modul redegør Søren Tang Knudsen for fordele og ulemper v…

<script src="https://fast.wistia.com/embed/medias/aj9h298coq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_aj9h298coq videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:17

Valg af diabetes behandling

Den medicinske behandling er hjørnestenen i den kliniske indsats v…

<script src="https://fast.wistia.com/embed/medias/6mfzajylqm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6mfzajylqm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:05

Nytter livsstilsændringer ved type 2-diabetes?

Det er meget svært at ændre sin livsstil. Derfor er de…

<script src="https://fast.wistia.com/embed/medias/3s61uveub3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3s61uveub3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
07:09

Multifarmakologisk intervention ved Type 2-diabetes

Vi ved at god glykæmisk…

<script src="https://fast.wistia.com/embed/medias/zeh13v5hxy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zeh13v5hxy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:31

Effekten af kirurgisk behandling

Der er indikation for kirurgisk behandling af svær over…

<script src="https://fast.wistia.com/embed/medias/rnqbwfhkxn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rnqbwfhkxn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:31

Effekten af farmakologisk behandling

Hvordan virker medicinsk…

<script src="https://fast.wistia.com/embed/medias/b0l13lf5mx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_b0l13lf5mx videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:44

Effekten af livsstilsintervention

Hvilken kostændring er bedst i forhold til at reducere sin kropsv…

<script src="https://fast.wistia.com/embed/medias/d40wykyohg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_d40wykyohg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:07

Hvordan udvikles svær overvægt

Overvægt handler ikke kun om, at man spiser mere, end man forbruge…

<script src="https://fast.wistia.com/embed/medias/xevhvj7ls6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xevhvj7ls6 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:44

Medicinsk støtte til vægttab

Der 3 muligheder for medicinsk behandling af overvægt, som gennemg…

<script src="https://fast.wistia.com/embed/medias/r4a9xqak6l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_r4a9xqak6l videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
12:56

Patientdialog om vægttabsforløb

Praktiserende læge Pia Müller har en dialog med en af sine patien…

<script src="https://fast.wistia.com/embed/medias/tiln0l9b17.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tiln0l9b17 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:23

Tips og tricks til patientforløb om vægttab

Spørgsmål til Pia Müller om tips og tricks til patientforløb om…

<script src="https://fast.wistia.com/embed/medias/cz7t3vw7oa.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_cz7t3vw7oa videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:49

Komorbiditet og fysisk aktivitet ved overvægt

I dette modul gennemgår praktiserende læge Pia Müller de hyppigs…

<script src="https://fast.wistia.com/embed/medias/3b5gfwkiha.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3b5gfwkiha videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:49

Motivation til vægttab

Motivation er alfa og omega for adfærdsændringer og dermed også …

<script src="https://fast.wistia.com/embed/medias/xr46gplt6x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xr46gplt6x videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Hvordan reduceres steroidforbruget hos patienter med KOL?

<script src="https://fast.wistia.com/embed/medias/tjn0xyrl7x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tjn0xyrl7x videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
22:48

Når diabetespatienten har hjertesygdom og hjertepatienten har diabetes

Patienter med diabetes har fortsat 50-60 % overdødeligh…

<script src="https://fast.wistia.com/embed/medias/ya9ymgx2gw.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ya9ymgx2gw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:57

Malaria

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/0xkkd46yry.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xkkd46yry videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:36

Rejsediarre

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/3hdrai9sio.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3hdrai9sio videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Rejsevaccination

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/2wyver70bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2wyver70bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Hepatitis A og B

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/716satyxgp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_716satyxgp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
02:52

Hjælpemidler til tjek af inhalationsteknik

Der findes forskellige hjælpemidler, der kan give en indikation af…

<script src="https://fast.wistia.com/embed/medias/qg6r27lwvv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qg6r27lwvv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
05:23

Valg af inhalator

Husk at meget medicin findes i flere forskellige inhalatorer – v…

<script src="https://fast.wistia.com/embed/medias/65vtwhwwlg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_65vtwhwwlg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:36

KOL og udfordringer med inhalationsteknik

Vi følger guidelines, men glemmer tit at tjekke det væsentlige: k…

<script src="https://fast.wistia.com/embed/medias/3qsk69sg11.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3qsk69sg11 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
06:24

De forskellige inhalatorer

Har du overblik? Der findes mange forskellige inhalatorer med den s…

<script src="https://fast.wistia.com/embed/medias/19jel19618.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_19jel19618 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 2:25

Ny lysbehandling til patienter med plaque psoriasis

Verdens første fototerapi til behandling af mild til moderat plaque p…

<script src="https://fast.wistia.com/embed/medias/kjl998ujwy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kjl998ujwy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:25

Blue Light og forskning

I dette modul af BestPractice MEDtalk om Philips Blue Light teknolo…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Philips Blue Light Control

Professor Matthias Born viser i dette modul af BestPractice MEDtalk…

<script src="https://fast.wistia.com/embed/medias/o6ebt6z3s9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o6ebt6z3s9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:27

Klinisk dokumentation

I dette modul af BestPractice Medtalk gennemgår Professor Matthias…

<script src="https://fast.wistia.com/embed/medias/qpwlz04pd0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qpwlz04pd0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Ny behandling til plaquepsoriasis

En ny type fototerapi fra Philips er udviklet til behandling af pla…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Caroline Kistrup MEDtalk 30. maj 2017 21:31

Type 2-diabetes hos patienter med anden etnisk baggrund

Forekomsten af type 2-diabetes blandt eksempelvis efterkommere fra …

<script src="https://fast.wistia.com/embed/medias/30di3i0oad.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_30di3i0oad videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
17:56

Nye GOLD-guidelines

GOLD-guidelines til behandling af KOL er blevet opdateret me…

<script src="https://fast.wistia.com/embed/medias/mue93jhp0n.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mue93jhp0n videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:47

Risikoen for stroke er vigtigere end for blødning

Risikoen for stroke er vigtigst AK-behandling er e…

<script src="https://fast.wistia.com/embed/medias/qqwddu8n5s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qqwddu8n5s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:56

Pas på med reduceret AK-dosis

Pas på med reduceret AK-dosis Det kan være frist…

<script src="https://fast.wistia.com/embed/medias/9ommd7u19c.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9ommd7u19c videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:52

Er warfarin og NOAK lige gode?

NOAK virker samlet set bedre end warfarin Studier,…

<script src="https://fast.wistia.com/embed/medias/891apdxyto.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_891apdxyto videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
22:00

Tryghed i din AK-behandling

Hør Torben Bjerregaard Larsen give pra…

<script src="https://fast.wistia.com/embed/medias/qyc92bz7vx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qyc92bz7vx videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:28

Levetiden er forkortet med op til 12 år ved type 2-diabetes

Omkring 2/3 af diabetespatienterne over 65 år dør af hjerte-karsygdo…

<script src="//fast.wistia.com/embed/medias/49eeiaamqu.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_49eeiaamqu videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:48

Reduceret kardiovaskulær mortalitet

Ved at ændre behandlingen af type 2-diabetes er det muligt at reducer…

<script src="//fast.wistia.com/embed/medias/efrp0405nm.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_efrp0405nm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:25

GLP-1 analog med kardiovaskulær beskyttende effekt

Nye resultater viser, at der er flere behandlingsmuligheder for at opn…

<script src="//fast.wistia.com/embed/medias/287pnsxzty.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_287pnsxzty videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:18

Paradigme skift i behandling af type 2-diabetes og hjerte-kar-sygdom

Hør Kenneth Egstrup fortælle om, hvorfor han mener, at vi står over…

<script src="//fast.wistia.com/embed/medias/umcl212b6s.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_umcl212b6s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
14:14

Behandlingsmuligheder ved svær overvægt

Forekomsten af svær overvægt er steget ganske betydeligt de senes…

<script src="//fast.wistia.com/embed/medias/e6o325u671.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_e6o325u671 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll MEDtalk BestPractice 2:48

Nye basalinsuliner bedrer blodsukkerkontrollen

Dine patienter kan få et mere stabilt blodsukkerniveau, hvis du v…

<script src="//fast.wistia.com/embed/medias/f05u112ff0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f05u112ff0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:30

AK-behandling ved AF

100.000 patienter i Danmark er i AK-behandling som følg…

<script src="//fast.wistia.com/embed/medias/2axxdw02fa.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2axxdw02fa videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Uffe Bødtger MEDtalk BestPractice 3:05

Sådan seponerer du inhalationssteroid ved KOL

Der har de senere år været fokus på …

<script src="//fast.wistia.com/embed/medias/au5f0929j0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_au5f0929j0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll MEDtalk BestPractice 2:48

Nye basalinsuliner bedrer blodsukkerkontrollen

Dine patienter kan få et mere stabilt blodsukkerniveau, hvis du vælg…

<script src="//fast.wistia.com/embed/medias/f05u112ff0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f05u112ff0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Jens Friberg MEDtalk BestPractice 5:33

Valg af AK-behandling ved AF? - Jens Friberg

100.000 patienter i Danmark er i AK-behandling som følg…

<script src="//fast.wistia.com/embed/medias/2axxdw02fa.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2axxdw02fa videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Uffe Bødtker MEDtalk BestPractice 3:04

Sådan seponerer du inhalationssteroid ved KOL

Der har de senere år været fokus på …

<script src="//fast.wistia.com/embed/medias/au5f0929j0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_au5f0929j0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Kenneth Egstrup BestPractice webinar 27:40

Behandling af kardiovaskulær sygdom og samtidig type 2-diabetes

<script src="//fast.wistia.com/embed/medias/3mmlrprgmj.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3mmlrprgmj videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Jens Friberg AK-behandling - Nye resultater fra almen praksis 19:20

AK-behandling - Nye resultater fra almen praksis

Omkring 100.000 patienter i Danmark er i AK-behandling som følge a…

<script src="//fast.wistia.com/embed/medias/pjyigjk724.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pjyigjk724 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll 26:30

Nye insuliner og kombinationsmuligheder

Antallet af glukosereducerende lægemidler har været stærkt stige…

<script src="//fast.wistia.com/embed/medias/imve6n5pqs.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_imve6n5pqs videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
22:48

Nye resultater ved KOL-behandling

Grundstammen i KOL-behandling er inhaleret bronkodilatator, men man…

<script src="//fast.wistia.com/embed/medias/2vur541hg2.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2vur541hg2 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Ulrik Pedersen-Bjergaard 25:27

Hypoglykæmi ved type 2-diabetes - set i patientperspektiv

Hypoglykæmi ved type 2-diabetes er en bivirkning til behandlingen,…

<script src="//fast.wistia.com/embed/medias/w5au0wvmga.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_w5au0wvmga videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Pernille Corell 22:10

Balancér blødningsrisiko og AK-behandling

Vi har talt med praktiserende læger om blødningsrisiko og AK-beha…

<script src="//fast.wistia.com/embed/medias/pbq4agscr5.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script> <div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pbq4agscr5 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Ander Løkke 33:31

Optimal terapivalg ved KOL - ICS, LABA og/eller LAMA

Optimal terapivalg ved KOL – ICS, LABA og/eller LAMA KOL er en af d…

<script src="//fast.wistia.com/embed/medias/vftsd6wf2j.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vftsd6wf2j videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Caroline Bruun Abild og Bjørn Richelsen MEDtalk BestPractice 25:41

Påvirk vægten ved diabetes

<script src="//fast.wistia.com/embed/medias/n29oakz1nc.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_n29oakz1nc videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Uffe Bødtker 23:05

Optimér kombinationerne i KOL-behandlingen

Flere hundrede præparater og behandlingskombinationer til KOL er e…

<script src="//fast.wistia.com/embed/medias/04xm2c2yyw.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_04xm2c2yyw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Steen Madsbad 35:29

Nyt om antidiabetika og CV-risiko. Hvad viser de nyeste studier?

Øger antidiabetika den kardiovaskulære risiko? Patienter med diab…

<script src="//fast.wistia.com/embed/medias/r1a80p1axp.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_r1a80p1axp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Bestpractice webinar med Ulrik Pedersen-Bjergaard og Hanne Holdflod Nørgaard 21:30

Kørekort og diabetes - overblik og praktiske tips

Reglerne er en balancegang for både læge og patient, specielt m.h…

<script src="//fast.wistia.com/embed/medias/1hz8mhu1ux.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1hz8mhu1ux videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Jørgen Rungby 37:14

Sådan behandler du individuelt diabetes og hjerte-kar-sygdom

Patienter med diabetes har en generel øget risiko for at udvikle h…

<script src="//fast.wistia.com/embed/medias/p4d50hta0a.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_p4d50hta0a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Jørgen Rungby MEDtalk BestPractice 25:22

Nyren og diabetes

<script src="//fast.wistia.com/embed/medias/vq9lbob7g8.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vq9lbob7g8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Pernille Corell 41:42

Kolesterolsænkning - the lower the better?

Der er solid dokumentation for, at reduktion af LDL-niveauet reduce…

<script src="//fast.wistia.com/embed/medias/afw6q7ohu4.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_afw6q7ohu4 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Apoteket

6:36

Hvad skal få mig, som læge, til at tænke ADHD?

I denne MEDtalk beskriver speciallæge i børne-/ungepsykiatri Jaco…

<script src="https://fast.wistia.com/embed/medias/yji6kccwys.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yji6kccwys videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:14

Klassiske senkomplikationer ved type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/64ekomhzrm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_64ekomhzrm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:44

Gode grunde til at seponere inhalationssteroid

Pensioneret praktiserende læge, nu lægevikar, Mogens Jacobsen gen…

<script src="https://fast.wistia.com/embed/medias/px72uhb0tr.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_px72uhb0tr videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:05

Nytter livsstilsændringer ved type 2-diabetes?

Det er meget svært at ændre sin livsstil. Derfor er de…

<script src="https://fast.wistia.com/embed/medias/3s61uveub3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3s61uveub3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:44

Effekten af livsstilsintervention

Hvilken kostændring er bedst i forhold til at reducere sin kropsv…

<script src="https://fast.wistia.com/embed/medias/d40wykyohg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_d40wykyohg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:49

Motivation til vægttab

Motivation er alfa og omega for adfærdsændringer og dermed også …

<script src="https://fast.wistia.com/embed/medias/xr46gplt6x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xr46gplt6x videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:57

Malaria

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/0xkkd46yry.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xkkd46yry videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:36

Rejsediarre

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/3hdrai9sio.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3hdrai9sio videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Rejsevaccination

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/2wyver70bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2wyver70bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Hepatitis A og B

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/716satyxgp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_716satyxgp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
02:52

Hjælpemidler til tjek af inhalationsteknik

Der findes forskellige hjælpemidler, der kan give en indikation af…

<script src="https://fast.wistia.com/embed/medias/qg6r27lwvv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qg6r27lwvv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
05:23

Valg af inhalator

Husk at meget medicin findes i flere forskellige inhalatorer – v…

<script src="https://fast.wistia.com/embed/medias/65vtwhwwlg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_65vtwhwwlg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:36

KOL og udfordringer med inhalationsteknik

Vi følger guidelines, men glemmer tit at tjekke det væsentlige: k…

<script src="https://fast.wistia.com/embed/medias/3qsk69sg11.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3qsk69sg11 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
06:24

De forskellige inhalatorer

Har du overblik? Der findes mange forskellige inhalatorer med den s…

<script src="https://fast.wistia.com/embed/medias/19jel19618.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_19jel19618 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 2:25

Ny lysbehandling til patienter med plaque psoriasis

Verdens første fototerapi til behandling af mild til moderat plaque p…

<script src="https://fast.wistia.com/embed/medias/kjl998ujwy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kjl998ujwy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Ny behandling til plaquepsoriasis

En ny type fototerapi fra Philips er udviklet til behandling af pla…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Caroline Kistrup MEDtalk 30. maj 2017 21:31

Type 2-diabetes hos patienter med anden etnisk baggrund

Forekomsten af type 2-diabetes blandt eksempelvis efterkommere fra …

<script src="https://fast.wistia.com/embed/medias/30di3i0oad.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_30di3i0oad videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
17:56

Nye GOLD-guidelines

GOLD-guidelines til behandling af KOL er blevet opdateret me…

<script src="https://fast.wistia.com/embed/medias/mue93jhp0n.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mue93jhp0n videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:47

Risikoen for stroke er vigtigere end for blødning

Risikoen for stroke er vigtigst AK-behandling er e…

<script src="https://fast.wistia.com/embed/medias/qqwddu8n5s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qqwddu8n5s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:52

Er warfarin og NOAK lige gode?

NOAK virker samlet set bedre end warfarin Studier,…

<script src="https://fast.wistia.com/embed/medias/891apdxyto.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_891apdxyto videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:28

Levetiden er forkortet med op til 12 år ved type 2-diabetes

Omkring 2/3 af diabetespatienterne over 65 år dør af hjerte-karsygdo…

<script src="//fast.wistia.com/embed/medias/49eeiaamqu.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_49eeiaamqu videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:48

Reduceret kardiovaskulær mortalitet

Ved at ændre behandlingen af type 2-diabetes er det muligt at reducer…

<script src="//fast.wistia.com/embed/medias/efrp0405nm.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_efrp0405nm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll MEDtalk BestPractice 2:48

Nye basalinsuliner bedrer blodsukkerkontrollen

Dine patienter kan få et mere stabilt blodsukkerniveau, hvis du vælg…

<script src="//fast.wistia.com/embed/medias/f05u112ff0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f05u112ff0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Dermatologi

1:59

Svigt af standard immunterapi ved malign melanom

Patienter med metastaserende malign melanom, der ikke responderer suff…

<script src="https://fast.wistia.com/embed/medias/rjzf31xt2l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rjzf31xt2l videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:25

Blue Light og forskning

I dette modul af BestPractice MEDtalk om Philips Blue Light teknolo…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Philips Blue Light Control

Professor Matthias Born viser i dette modul af BestPractice MEDtalk…

<script src="https://fast.wistia.com/embed/medias/o6ebt6z3s9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o6ebt6z3s9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:27

Klinisk dokumentation

I dette modul af BestPractice Medtalk gennemgår Professor Matthias…

<script src="https://fast.wistia.com/embed/medias/qpwlz04pd0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qpwlz04pd0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Ny behandling til plaquepsoriasis

En ny type fototerapi fra Philips er udviklet til behandling af pla…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Gastroenterologi

3:53

Effektvurdering ved opstart

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/3a59clzz8n.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3a59clzz8n videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:21

Valg af behandling af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/nuls6tsqsb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_nuls6tsqsb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:33

Optimering af behandlingen af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/5m6lwbm3ao.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_5m6lwbm3ao videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:37

Mål for behandlingen af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/gvd82auyhm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gvd82auyhm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:19

Nyt i behandlingen af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/za3ggsejjv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_za3ggsejjv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Stefan Schreiber rebyggelse af sygdomsprogression 2:00

Forebyggelse af sygdomsprogression

I dette modul af BestPractice MEDtalk med Professor, ind…

<script src="https://fast.wistia.com/embed/medias/tl9v7px26s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tl9v7px26s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:15

Vedolizumab til behandling af Crohns sygdom samt Colitis Ulcerosa

I dette modul af BestPractice MEDtalk med Professor, i g…

<script src="https://fast.wistia.com/embed/medias/9in2l55v37.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9in2l55v37 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:57

Behandlingsskift – tid til at ordeinere noget andet?

Professor, i gastroenterologi, Stefan Schreiber fra Kiel…

<script src="https://fast.wistia.com/embed/medias/izdr9171ea.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_izdr9171ea videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:17

STRIDE og treat-to-target anbefalinger

I dette modul af BestPractice MEDtalk præsenterer Profe…

<script src="https://fast.wistia.com/embed/medias/h2u9fi6wfh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_h2u9fi6wfh videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Hæmatologi

3:19

Hurtigere diagnostik af myelomatose

Med ganske få virkemidler er det muligt at afgøre, om dine patien…

<script src="https://fast.wistia.com/embed/medias/vlld4boamp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vlld4boamp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:13

CLL-highlights - flere interessante kliniske data

Klik og hør en kort redegørelse om de seneste kliniske resultater…

<script src="https://fast.wistia.com/embed/medias/u8gg77ezij.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_u8gg77ezij videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:14

Betydningen af IGHV-staus for behandling af CLL

Hør Emelie Curovic Rotbain, MD, Hæmatologisk afdeling, Rigshospit…

<script src="https://fast.wistia.com/embed/medias/gua1je7l53.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gua1je7l53 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:21

Nivolumab - en veltolereret behandling af patienter med Hodgkin Lymfom

Nivolumab som monoterapi efterfulgt af kombinationsbehandling med nivo…

<script src="https://fast.wistia.com/embed/medias/rc3vhb4t5v.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rc3vhb4t5v videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:30

Vurdering af prognosen for CLL-patienter med B-Celle receptor stereotypi

Nye data peger frem mod en mere individuel vurdering af den enkelte pa…

<script src="https://fast.wistia.com/embed/medias/zbys3evsy5.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zbys3evsy5 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:27

Imponerende data om CLL

På flere sessioner blev der præsenteret nye resultater for behandlin…

<script src="https://fast.wistia.com/embed/medias/4h3qro4oia.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4h3qro4oia videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:08

Fortsat nivolumab-behandling ved Hodgkin lymfom

Patienter med relapse/refraktær klassisk Hodgkin lymfom behandlet me…

<script src="https://fast.wistia.com/embed/medias/gijis4ribt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gijis4ribt videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:30

Nyt om kuldeagglutinin syndrom og CLL

Ny behandling er nu en mulighed, ifølge Henrik Hjorth-Hasnen, for pat…

<script src="https://fast.wistia.com/embed/medias/0evjwm7g10.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0evjwm7g10 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:29

Større følsomhed for BCL2-hæmmer ved CLL

Behandlingen af CLL er i en ny æra med flere nye behandlingsmulighede…

<script src="https://fast.wistia.com/embed/medias/qnpnm4irso.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qnpnm4irso videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:04

Risiko for dyb venetrombose og lungemboli ved cancer kan reduceres

Incidensen af venøs tromboemboli hos indlagte patienter med aktiv can…

<script src="https://fast.wistia.com/embed/medias/sgcwgexibb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sgcwgexibb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Styring af behandlingsresponset

Valg af førstelinjebehandling ved myelomatose, styring af behandli…

<script src="https://fast.wistia.com/embed/medias/hmsoa1fp2g.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hmsoa1fp2g videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Paradigmeskift for brug af MRD

Minimal residual disease, MRD; var fokus ved flere interessante ses…

<script src="https://fast.wistia.com/embed/medias/mcn6ssj2bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mcn6ssj2bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:48

Ophør af TKI-behandling ved CML

Varigheden af “Deep Molecular Response er den vigtigste faktor i fo…

<script src="https://fast.wistia.com/embed/medias/6gizwg2552.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6gizwg2552 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:13

Opsigtsvækkende resultater

Patienter med avanceret Hodgkin Lymfom i stadie III or IV kan med e…

<script src="https://fast.wistia.com/embed/medias/sxszhos9ye.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sxszhos9ye videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:05

Myelomatose i dansk perspektiv

Danske hæmatologer medvirkede ved to klinisk vigtig…

<script src="https://fast.wistia.com/embed/medias/gtswg4z10f.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gtswg4z10f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:44

Ældre CLL-patienter får flest infektioner

Dansk registerstudie belyser forekomsten af infektioner hos patienter …

<script src="https://fast.wistia.com/embed/medias/136l423oq8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_136l423oq8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:18

Prædiagnostisk progression af lymphocytose ved CLL

Kronisk lymfatisk leukæmi (CLL) er en heterogen sygdom der udvikle…

<script src="https://fast.wistia.com/embed/medias/sin4qn3gvn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sin4qn3gvn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:57

Behov for nye kombinationsbehandlinger for mere varig remission

Trods den bemærkelsesværdige effekt med de ny…

<script src="https://fast.wistia.com/embed/medias/4ebkzqkxps.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4ebkzqkxps videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:44

Behandlingsfri remission – et muligt nyt behandlingsmål for patienter med CML-CP

Evnen til at stoppe TKI behandling uden at miste respons (dvs.: TFR…

<script src="https://fast.wistia.com/embed/medias/mspznl86za.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mspznl86za videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:47

Ny frontline behandling til yngre CLL-patienter

I 2016 viste RESONATE-2 studiet, at Ibrutinib, Imbruvica, kan anven…

<script src="https://fast.wistia.com/embed/medias/sw991po4zb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sw991po4zb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:06

Stort fremskridt for behandling af myelomatose

Fremlæggelsen af langti…

<script src="https://fast.wistia.com/embed/medias/kmii8lc65o.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kmii8lc65o videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:06

MRD negativitet har stor klinisk betydning

Flere nye data viser, at…

<script src="https://fast.wistia.com/embed/medias/kgzgkhjdrk.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kgzgkhjdrk videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:36

Ny standard for fremtidig behandling af myelomatose

Hør Jesús F. San-Miguel fremlægge nogle de mest …

<script src="https://fast.wistia.com/embed/medias/uvpq38k04d.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_uvpq38k04d videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:33

Behandling af follikulært lymfom

I denne MEDtalk redegør professor Andrew Davies, University af So…

<script src="https://fast.wistia.com/embed/medias/1z418ed2j3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1z418ed2j3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:55

How to treat patients in relapse following frontline ASCT

Hør professor Philippe Moreau, redegøre for to cen…

<script src="https://fast.wistia.com/embed/medias/dhhiqsxeii.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_dhhiqsxeii videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
13:24

Sequencing therapy in multiple myeloma

Hør professor Philippe Moreau, redegøre for to cen…

<script src="https://fast.wistia.com/embed/medias/9a35p1qboe.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9a35p1qboe videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Eivind Galteland og Carsten Niemann i CLL MEDtalk 13:53

Faglig diskussion om CLL behandling

Hør Carsten Niemann og Eivind Galteland diskutere to ka…

<script src="//fast.wistia.com/embed/medias/62awlmxb7f.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_62awlmxb7f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Philippe Moreau MEDtalk myelomatose 28:12

Behandling af myelomatose

Behandlingen af myelomatose er i en forrygende udvikling i disse å…

<script src="//fast.wistia.com/embed/medias/u9a8zol34b.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_u9a8zol34b videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Carsten Niemann MEDtalk KLL 23:44

Kronisk lymfatisk leukæmi - Update

Hør Carsten Niemanns opdatering på de danske guidelines for CLL. …

<script src="//fast.wistia.com/embed/medias/fshz4mhvr8.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_fshz4mhvr8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

ASH 2017

4:14

Betydningen af IGHV-staus for behandling af CLL

Hør Emelie Curovic Rotbain, MD, Hæmatologisk afdeling, Rigshospit…

<script src="https://fast.wistia.com/embed/medias/gua1je7l53.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gua1je7l53 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:21

Nivolumab - en veltolereret behandling af patienter med Hodgkin Lymfom

Nivolumab som monoterapi efterfulgt af kombinationsbehandling med nivo…

<script src="https://fast.wistia.com/embed/medias/rc3vhb4t5v.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rc3vhb4t5v videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:30

Vurdering af prognosen for CLL-patienter med B-Celle receptor stereotypi

Nye data peger frem mod en mere individuel vurdering af den enkelte pa…

<script src="https://fast.wistia.com/embed/medias/zbys3evsy5.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zbys3evsy5 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:27

Imponerende data om CLL

På flere sessioner blev der præsenteret nye resultater for behandlin…

<script src="https://fast.wistia.com/embed/medias/4h3qro4oia.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4h3qro4oia videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:08

Fortsat nivolumab-behandling ved Hodgkin lymfom

Patienter med relapse/refraktær klassisk Hodgkin lymfom behandlet me…

<script src="https://fast.wistia.com/embed/medias/gijis4ribt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gijis4ribt videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:30

Nyt om kuldeagglutinin syndrom og CLL

Ny behandling er nu en mulighed, ifølge Henrik Hjorth-Hasnen, for pat…

<script src="https://fast.wistia.com/embed/medias/0evjwm7g10.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0evjwm7g10 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:29

Større følsomhed for BCL2-hæmmer ved CLL

Behandlingen af CLL er i en ny æra med flere nye behandlingsmulighede…

<script src="https://fast.wistia.com/embed/medias/qnpnm4irso.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qnpnm4irso videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:04

Risiko for dyb venetrombose og lungemboli ved cancer kan reduceres

Incidensen af venøs tromboemboli hos indlagte patienter med aktiv can…

<script src="https://fast.wistia.com/embed/medias/sgcwgexibb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sgcwgexibb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Styring af behandlingsresponset

Valg af førstelinjebehandling ved myelomatose, styring af behandli…

<script src="https://fast.wistia.com/embed/medias/hmsoa1fp2g.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hmsoa1fp2g videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Paradigmeskift for brug af MRD

Minimal residual disease, MRD; var fokus ved flere interessante ses…

<script src="https://fast.wistia.com/embed/medias/mcn6ssj2bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mcn6ssj2bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:48

Ophør af TKI-behandling ved CML

Varigheden af “Deep Molecular Response er den vigtigste faktor i fo…

<script src="https://fast.wistia.com/embed/medias/6gizwg2552.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6gizwg2552 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:13

Opsigtsvækkende resultater

Patienter med avanceret Hodgkin Lymfom i stadie III or IV kan med e…

<script src="https://fast.wistia.com/embed/medias/sxszhos9ye.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sxszhos9ye videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:05

Myelomatose i dansk perspektiv

Danske hæmatologer medvirkede ved to klinisk vigtig…

<script src="https://fast.wistia.com/embed/medias/gtswg4z10f.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gtswg4z10f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:44

Ældre CLL-patienter får flest infektioner

Dansk registerstudie belyser forekomsten af infektioner hos patienter …

<script src="https://fast.wistia.com/embed/medias/136l423oq8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_136l423oq8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:18

Prædiagnostisk progression af lymphocytose ved CLL

Kronisk lymfatisk leukæmi (CLL) er en heterogen sygdom der udvikle…

<script src="https://fast.wistia.com/embed/medias/sin4qn3gvn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sin4qn3gvn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:57

Behov for nye kombinationsbehandlinger for mere varig remission

Trods den bemærkelsesværdige effekt med de ny…

<script src="https://fast.wistia.com/embed/medias/4ebkzqkxps.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4ebkzqkxps videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:44

Behandlingsfri remission – et muligt nyt behandlingsmål for patienter med CML-CP

Evnen til at stoppe TKI behandling uden at miste respons (dvs.: TFR…

<script src="https://fast.wistia.com/embed/medias/mspznl86za.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mspznl86za videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:47

Ny frontline behandling til yngre CLL-patienter

I 2016 viste RESONATE-2 studiet, at Ibrutinib, Imbruvica, kan anven…

<script src="https://fast.wistia.com/embed/medias/sw991po4zb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sw991po4zb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:06

Stort fremskridt for behandling af myelomatose

Fremlæggelsen af langti…

<script src="https://fast.wistia.com/embed/medias/kmii8lc65o.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kmii8lc65o videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:06

MRD negativitet har stor klinisk betydning

Flere nye data viser, at…

<script src="https://fast.wistia.com/embed/medias/kgzgkhjdrk.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kgzgkhjdrk videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:36

Ny standard for fremtidig behandling af myelomatose

Hør Jesús F. San-Miguel fremlægge nogle de mest …

<script src="https://fast.wistia.com/embed/medias/uvpq38k04d.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_uvpq38k04d videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Neurologi

4:48

Ibudilast til MS

Matthias Kant, leder af sydjysk skleroseklinik på Sønderborg Syge…

<script src="https://fast.wistia.com/embed/medias/6zac3mx3z0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6zac3mx3z0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:54

Paradigme studiet – pædiatriske patienter

Matthias Kant, leder af sydjysk skleroseklinik på Sønderborg Syge…

<script src="https://fast.wistia.com/embed/medias/0ex5r83ytd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0ex5r83ytd videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Opdatering af McDonalds kriterierne

Matthias Kant, leder af sydjysk skleroseklinik på Sønderborg Syge…

<script src="https://fast.wistia.com/embed/medias/7o23wiursr.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_7o23wiursr videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:44

Nyt primært endepunkt i kliniske forsøg

Leder af sydjysk sklerose klinik på Sønderborg Sygehus, Mathias K…

<script src="https://fast.wistia.com/embed/medias/uwqtpjvbjj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_uwqtpjvbjj videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
13:00

Resetting af immunsystemet  ved multippel sklerose

Behandlingstrategierne ved multippel sklerose har ændret sig over …

<script src="https://fast.wistia.com/embed/medias/m6cd5pqtlx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_m6cd5pqtlx videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Graviditet og MS

Omfanget af uplanlagte graviditeter hos kvinder med MS kendes ikke …

<script src="https://fast.wistia.com/embed/medias/pupg6bznlu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pupg6bznlu videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:06

Nye data for Ocrelizumab

 I denne MEDtalk redegør Morten Blinkenberg, overlæge, ph.d., D…

<script src="https://fast.wistia.com/embed/medias/gxiigc6fq3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gxiigc6fq3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:55

Langtids-lymfocyttal hos patienter behandlet med cladribin-tabletter

Behandling med cladribin kan karakteriseres som pulsed immune r…

<script src="https://fast.wistia.com/embed/medias/6un6x0sh5y.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6un6x0sh5y videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
12:43

Kognitive vanskeligheder ved MS

Kognitive gener ved MS er udbredt. 

<script src="https://fast.wistia.com/embed/medias/2bwfzlbria.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2bwfzlbria videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:06

Nye langtidsdata på Lemtrada (alemtuzumab)

Claudia Pfleger, overlæge på neurologisk afd. Ålborg Universitet…

<script src="https://fast.wistia.com/embed/medias/k8nf6uj5fy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_k8nf6uj5fy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Onkologi

10:35

Highlights fra ESMO om immunterapi

I alt 45 sessioner ved ESMO konferencen omhandlede immunterapi og er e…

<script src="https://fast.wistia.com/embed/medias/9vv4edsj37.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9vv4edsj37 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Paradigmeskift på vej i behandling af lungecancer

Data fra PACIFIK-studiet viser, at immunterapi tredobler overlevelsen …

<script src="https://fast.wistia.com/embed/medias/47gkpopgyn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_47gkpopgyn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:40

Vigtigt med fagligt netværk for sjældne kræftsygdomme

Sjældne cancersygdomme er ofte aggressive og rammer ofte yngre patien…

<script src="https://fast.wistia.com/embed/medias/0pu4qtgben.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0pu4qtgben videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:05

Immunterapi giver bedre progresionsfri overlevelse end strålebehandling ved lungecancer

Overlæge Åslaug Helland, OUS, giver her en kort status på de nye da…

<script src="https://fast.wistia.com/embed/medias/a9n7koxp27.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_a9n7koxp27 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Bedre overlevelse for patienter med prostatacancer

Overlæge Jan Oldenburg, Akershus Universitetssykehus, giver sit syn p…

<script src="https://fast.wistia.com/embed/medias/dn7ymce718.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_dn7ymce718 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:43

Nyt håb for patienter med højrisiko malign melanom

Ifølge Karl Lewis, associate professor of medicine, Division of Medic…

<script src="https://fast.wistia.com/embed/medias/0qvm9agklb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0qvm9agklb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:21

Adjuverende immunterapi ved BRAF V600E muteret malign melanom

Karl Lewis, an associate professor of medicine, Division of Medical On…

<script src="https://fast.wistia.com/embed/medias/va52eq0kzl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_va52eq0kzl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:41

T-celle terapi mod ovariecancer

Magnus Pedersen, Center for cancer immunterapi, Herlev Hospital, freml…

<script src="https://fast.wistia.com/embed/medias/sef6qf1hsd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sef6qf1hsd videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:24

Ny kandidat til 1. linjebehandling af EGFR-muteret ikke-småcellet lungecancer

Suresh S. Ramalingam, professor, Director, Winship Cancer Institute,…

<script src="https://fast.wistia.com/embed/medias/titpuwihd9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_titpuwihd9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Svigt af standard immunterapi ved malign melanom

Patienter med metastaserende malign melanom, der ikke responderer suff…

<script src="https://fast.wistia.com/embed/medias/rjzf31xt2l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rjzf31xt2l videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Pembrolizumab - ny standard som andenlinje behandling ved blærecancer

Behandling med Pembrolizumab tolereres godt, forlænger overlevelsen o…

<script src="https://fast.wistia.com/embed/medias/2cirz7lg4f.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2cirz7lg4f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:37

Vaccine mod ikke-småcellet lungecancer i stadie III-IV

Kan vaccine blive en fremtidig behandling af lungecancer? Svaret på d…

<script src="https://fast.wistia.com/embed/medias/qp2gw1iw3w.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qp2gw1iw3w videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Atezolizumab signifikant bedre end docetaxel som andenlinje behandling

På ESMO 2016 Copenhagen redegjorde Fabrice Barlesi for resultaterne f…

<script src="https://fast.wistia.com/embed/medias/ijztiuaopo.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ijztiuaopo videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:30

Hvordan skal PD-L1 ekspressionen anvendes ved behandling af lungecancer?

Behandlingen af lungecancer bliver mere komplekst, men de mange nye da…

<script src="https://fast.wistia.com/embed/medias/3pzox0wb58.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3pzox0wb58 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:12

”Real life” patienter med malign melanom adskiller sig fra patienter, der indgår i fase-III studier

Dansk studie har undersøgt, i hvor høj grad ”real-life” patiente…

<script src="https://fast.wistia.com/embed/medias/0qsmq6av4y.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0qsmq6av4y videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:59

Neurotoksitet forringer livskvaliteten hos overlevere efter testikelcancer

Mange patienter med testikelcancer overlever i dag deres cancersygdom …

<script src="https://fast.wistia.com/embed/medias/4eviboybjm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4eviboybjm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Nye resultater der vil ændre den kliniske praksis ved behandling af lungecancer

Hør Lecia V. Sequist, MD, MPH, Massachusets General Hospital Cancer…

<script src="https://fast.wistia.com/embed/medias/8ran4yhs1b.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_8ran4yhs1b videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Alice T. Shaw from ESMO 2016 in Copenhagen 3:25

Betydningen af at teste for ALK og ROS 1 mutation

Hør Alice T. Shaw, Massachusets General Hospital Cancer Center, B…

<script src="//fast.wistia.com/embed/medias/cob4bticfm.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_cob4bticfm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
ESMO 2016 sammendrag BestPractice 42:34

Ny epoke i behandlingen af lungecancer

Der kan med rette være store forventninger til 2017. For det er nu…

<script src="//fast.wistia.com/embed/medias/b3mrtjpp0a.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_b3mrtjpp0a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEdtalk med Inge Marie Svane immunterapi patientcases 09:59

Patientcases - immunterapi

I dette modul gives eksempler på behandlingsforløb for kræftpati…

<script src="//fast.wistia.com/embed/medias/0uplr9dmy3.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0uplr9dmy3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Inge Marie Svane MEDtalk om immunterapi 13:18

Forekomst og håndtering af bivirkninger

Bivirkninger til immunterapi er forårsaget af et hyperaktivt immun…

<script src="//fast.wistia.com/embed/medias/8qzgno48fl.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_8qzgno48fl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEdtalk med Inge Marie Svane immunterapi vurdering af effekten 11:07

Vurdering af effekten ved immunterapi

Immunterapi adskiller sig markant fra anden kræftbehandling, når …

<script src="//fast.wistia.com/embed/medias/724vbj0tbn.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_724vbj0tbn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEdtalk med Inge Marie Svane immunterapi virkningsmekanismer 13:05

Immunterapi - virkningsmekanismer

Inge Marie Svane giver her en grundlæggende indføring i virknings…

<script src="//fast.wistia.com/embed/medias/hjr1nkjcrh.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hjr1nkjcrh videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

ESMO 2016

Alice T. Shaw from ESMO 2016 in Copenhagen 3:25

Betydningen af at teste for ALK og ROS 1 mutation

Hør Alice T. Shaw, Massachusets General Hospital Cancer Center, B…

<script src="//fast.wistia.com/embed/medias/cob4bticfm.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_cob4bticfm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
ESMO 2016 sammendrag BestPractice 42:34

Ny epoke i behandlingen af lungecancer

Der kan med rette være store forventninger til 2017. For det er nu…

<script src="//fast.wistia.com/embed/medias/b3mrtjpp0a.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_b3mrtjpp0a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

ESMO 2017

10:35

Highlights fra ESMO om immunterapi

I alt 45 sessioner ved ESMO konferencen omhandlede immunterapi og er e…

<script src="https://fast.wistia.com/embed/medias/9vv4edsj37.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9vv4edsj37 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Paradigmeskift på vej i behandling af lungecancer

Data fra PACIFIK-studiet viser, at immunterapi tredobler overlevelsen …

<script src="https://fast.wistia.com/embed/medias/47gkpopgyn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_47gkpopgyn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:40

Vigtigt med fagligt netværk for sjældne kræftsygdomme

Sjældne cancersygdomme er ofte aggressive og rammer ofte yngre patien…

<script src="https://fast.wistia.com/embed/medias/0pu4qtgben.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0pu4qtgben videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:05

Immunterapi giver bedre progresionsfri overlevelse end strålebehandling ved lungecancer

Overlæge Åslaug Helland, OUS, giver her en kort status på de nye da…

<script src="https://fast.wistia.com/embed/medias/a9n7koxp27.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_a9n7koxp27 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Bedre overlevelse for patienter med prostatacancer

Overlæge Jan Oldenburg, Akershus Universitetssykehus, giver sit syn p…

<script src="https://fast.wistia.com/embed/medias/dn7ymce718.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_dn7ymce718 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:43

Nyt håb for patienter med højrisiko malign melanom

Ifølge Karl Lewis, associate professor of medicine, Division of Medic…

<script src="https://fast.wistia.com/embed/medias/0qvm9agklb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0qvm9agklb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:21

Adjuverende immunterapi ved BRAF V600E muteret malign melanom

Karl Lewis, an associate professor of medicine, Division of Medical On…

<script src="https://fast.wistia.com/embed/medias/va52eq0kzl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_va52eq0kzl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:41

T-celle terapi mod ovariecancer

Magnus Pedersen, Center for cancer immunterapi, Herlev Hospital, freml…

<script src="https://fast.wistia.com/embed/medias/sef6qf1hsd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sef6qf1hsd videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:24

Ny kandidat til 1. linjebehandling af EGFR-muteret ikke-småcellet lungecancer

Suresh S. Ramalingam, professor, Director, Winship Cancer Institute,…

<script src="https://fast.wistia.com/embed/medias/titpuwihd9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_titpuwihd9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Svigt af standard immunterapi ved malign melanom

Patienter med metastaserende malign melanom, der ikke responderer suff…

<script src="https://fast.wistia.com/embed/medias/rjzf31xt2l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rjzf31xt2l videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Pembrolizumab - ny standard som andenlinje behandling ved blærecancer

Behandling med Pembrolizumab tolereres godt, forlænger overlevelsen o…

<script src="https://fast.wistia.com/embed/medias/2cirz7lg4f.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2cirz7lg4f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:37

Vaccine mod ikke-småcellet lungecancer i stadie III-IV

Kan vaccine blive en fremtidig behandling af lungecancer? Svaret på d…

<script src="https://fast.wistia.com/embed/medias/qp2gw1iw3w.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qp2gw1iw3w videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Psykiatri

11:52

Behandling af stress, angst og misbrug hos voksne med en grundlæggende ADHD-problematik

Jakob Ørnberg har sat sine to canadiske kolleger Martin Katzman og…

<script src="https://fast.wistia.com/embed/medias/t7pp1j8ira.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_t7pp1j8ira videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:38

Understanding neurobiology allow us to understand the trajectory

What can we learn from the neurobiology about ADHD and co-occurring…

<script src="https://fast.wistia.com/embed/medias/d3ni18cvjy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_d3ni18cvjy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:55

Why do clinicians often fail to diagnose ADHD in adults?

What signs and symptoms of ADHD, should you as a clinician ‘look …

<script src="https://fast.wistia.com/embed/medias/ulhqio1vtf.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ulhqio1vtf videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:36

Hvad skal få mig, som læge, til at tænke ADHD?

I denne MEDtalk beskriver speciallæge i børne-/ungepsykiatri Jaco…

<script src="https://fast.wistia.com/embed/medias/yji6kccwys.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yji6kccwys videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Reumatologi

20:08

Behandling af RA med JAK-hæmere - Kliniske erfaringer med fokus på tofacitinib

Ifølge de opdaterede EULAR guidelines er JAK-hæmmere nu et ligev…

<script src="https://fast.wistia.com/embed/medias/792p588n7p.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_792p588n7p videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
21:07

The importance of early diagnosis and new treatment of RA

This Medtalk is a conversation among former EULAR president and Pro…

<script src="https://fast.wistia.com/embed/medias/jipuwq3g6y.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jipuwq3g6y videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
12:58

Ny tabletbehandling til reumatoid artrit

Hør Tore Kristian Kvien, professor og afdelingschef, revmatologisk…

<script src="https://fast.wistia.com/embed/medias/zu64sdqb6c.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zu64sdqb6c videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Sygeplejersken

2:28

Myelomatose – materialer der kan hjælpe patient og pårørende

Myelomatose Foreningen har diverse støttematerialer, der kan være…

<script src="https://fast.wistia.com/embed/medias/j7lf7atgdj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j7lf7atgdj videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:45

Myelomatose – en reminder til at hjælpe i udredningen

Her får du viden om en god reminder lavet af Myelomatose Foreninge…

<script src="https://fast.wistia.com/embed/medias/2upk7gfomy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2upk7gfomy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:40

Myelomatose - en sygdom der let overses

Myelomatose, en ikke-kurabel hæmatologisk sygdom, hvis symptomer e…

<script src="https://fast.wistia.com/embed/medias/xq3bn7xp0s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xq3bn7xp0s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
20:50

Forekomst og behandling af kardiovaskulær sygdom hos diabetespatienter i almen praksis

En ny dansk undersøgelse viser, at et stort antal diabetespatiente…

<script src="https://fast.wistia.com/embed/medias/0xvytwmqjy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xvytwmqjy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:43

Spørgsmål fra almen praksis om type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/j69ca6c5pz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j69ca6c5pz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
12:34

Valg af behandling når patienten har type 2-diabetes og hjertesygdom

<script src="https://fast.wistia.com/embed/medias/m97eojk57i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_m97eojk57i videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:14

Klassiske senkomplikationer ved type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/64ekomhzrm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_64ekomhzrm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
22:48

Når diabetespatienten har hjertesygdom og hjertepatienten har diabetes

Patienter med diabetes har fortsat 50-60 % overdødeligh…

<script src="https://fast.wistia.com/embed/medias/ya9ymgx2gw.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ya9ymgx2gw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:57

Malaria

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/0xkkd46yry.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xkkd46yry videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:36

Rejsediarre

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/3hdrai9sio.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3hdrai9sio videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Rejsevaccination

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/2wyver70bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2wyver70bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Hepatitis A og B

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/716satyxgp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_716satyxgp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:25

Blue Light og forskning

I dette modul af BestPractice MEDtalk om Philips Blue Light teknolo…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Philips Blue Light Control

Professor Matthias Born viser i dette modul af BestPractice MEDtalk…

<script src="https://fast.wistia.com/embed/medias/o6ebt6z3s9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o6ebt6z3s9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:27

Klinisk dokumentation

I dette modul af BestPractice Medtalk gennemgår Professor Matthias…

<script src="https://fast.wistia.com/embed/medias/qpwlz04pd0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qpwlz04pd0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Ny behandling til plaquepsoriasis

En ny type fototerapi fra Philips er udviklet til behandling af pla…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>